HEALTH
From Times Staff and Wire Reports
FDA Gives OK for Syphilis, Ovarian Cancer Detection Tests: Centocor Inc. said it has received Food and Drug Administration approval to market the new diagnostic tests. The Malvern, Pa., company said its syphilis test, Captia Syphilis-G, is cleared for use in blood banks and testing laboratories. The test can be used as a primary screening method for certain antibodies in human serum or plasma. Centocor’s CA 125 II test will be used as an aid to detect residual epithelial ovarian cancer.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
